Trinity Biotech (TRIB) Stock Forecast, Price & News

Trinity Biotech's stock was trading at $0.99 at the beginning of 2023. Since then, TRIB stock has decreased by 10.1% and is now trading at $0.89.
View the best growth stocks for 2023 here.

Trinity Biotech saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 29,400 shares, a decline of 18.3% from the April 30th total of 36,000 shares. Based on an average daily volume of 36,200 shares, the short-interest ratio is presently 0.8 days.
View Trinity Biotech's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our TRIB earnings forecast.

Trinity Biotech plc (NASDAQ:TRIB) posted its earnings results on Thursday, March, 23rd. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.12. The firm earned $18.04 million during the quarter, compared to analysts' expectations of $18 million. Trinity Biotech had a negative net margin of 54.84% and a negative trailing twelve-month return on equity of 724.07%.

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

Trinity Biotech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Hunter Associates Investment Management LLC (4.66%), Renaissance Technologies LLC (3.61%), Aristides Capital LLC (0.43%), Envestnet Asset Management Inc. (0.14%) and Group One Trading L.P. (0.00%).

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRIB stock can currently be purchased for approximately $0.89.

Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $33.92 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis.

The company employs 543 workers across the globe.

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.